Products for Research Use Only
RegisterLogin

CFON-026

CAT: 0804-HY-174850Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-174850Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
CFON-026 is a selective, orally active and non-covalent BTK inhibitor with an IC50 of 0.27 nM. CFON-026 has significant antitumor activity against wild-type BTK (TMD8 and REC-1) and all clinically relevant BTK resistance mutations (BTK C481S, T474I, L528W and V416L) . CFON-026 induces complete tumor regression in TMD8 xenograft mice model. CFON-026 can be used for research of hematological cancers like chronic lymphocytic leukemia and waldenström macroglobulinemia[1].
CAS Number
2941611-57-8
UNSPSC
12352005
Target
Btk
Related Pathways
Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Smiles
NC1=NC=C2/C=C/CCCCCC(N[C@@H]3CCC[C@@H](C4=NC(C5=CC=C(C(NC6=CC(C#N)=CC=N6)=O)C=C5)=C1N24)C3)=O
Molecular Formula
C33H34N8O2
Molecular Weight
574.68
References & Citations
[1]Mil Y V, et al.151 (PB139) : CFON-026, a best-in-class macrocyclic non-covalent inhibitor of BTK (WT) and all clinically relevant BTK resistance mutations[J].European Journal of Cancer, 2024, 211.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-P990602IMA-026
HY-169264SJYHJ-026
HY-157318PB17-026-01
HY-U00005AD 0261
HY-178102SKLB-0266

Alternative Products

CatalogName
GTR19263590-01CFON-026
T200826-01SJYHJ-026
T26575-01AGI-026
GTR19259955-01KD-026
T208749-01PB17-026-01
NBP2-90189-100ulRabbit Monoclonal CCDC134 Antibody (026)
C00690-1mgAnti-IL-13 (IMA-026)
PTX26006Anti-Human IL13 (IMA-026)
NBP2-90309-100ulRabbit Monoclonal PIG3 Antibody (026)
NBP2-89326-100ulRabbit Monoclonal EphB6 Antibody (026)

Popular Products